Jiexin Li

3.8k total citations
64 papers, 2.3k citations indexed

About

Jiexin Li is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Jiexin Li has authored 64 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 14 papers in Cancer Research and 14 papers in Biomedical Engineering. Recurrent topics in Jiexin Li's work include RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (13 papers) and Cancer-related gene regulation (12 papers). Jiexin Li is often cited by papers focused on RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (13 papers) and Cancer-related gene regulation (12 papers). Jiexin Li collaborates with scholars based in China, United States and Iran. Jiexin Li's co-authors include Hongsheng Wang, Zhuojia Chen, Feng Chen, Yingmin Wu, Yanxi Peng, Haisheng Zhang, Guanmin Jiang, Yumiao Zhang, He Ren and Nan Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Jiexin Li

62 papers receiving 2.3k citations

Peers

Jiexin Li
Comparison fields: 5 of 109
  • Molecular Biology 1.8k
  • Cancer Research 1.1k
  • Electrical and Electronic Engineering 233
  • Oncology 217
  • Biomedical Engineering 210
Replace Yueming Sun with:
Yueming Sun China
Yihui Ma China
Ming Cao China
Xiaofei Zhang China
Qinglin Liu China
Xiaofan Ding China
Gongwei Wu China
Kouji Iida Japan
Yuanyuan Qiao China
Yueming Sun China View profile →
Citations per field, relative to Jiexin Li
Jiexin Li · 1×
Citations per year, relative to Jiexin Li
Jiexin Li · 1×

Countries citing papers authored by Jiexin Li

Since Specialization
Citations

This map shows the geographic impact of Jiexin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiexin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiexin Li more than expected).

Fields of papers citing papers by Jiexin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiexin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiexin Li. The network helps show where Jiexin Li may publish in the future.

Co-authorship network of co-authors of Jiexin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiexin Li. A scholar is included among the top collaborators of Jiexin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiexin Li. Jiexin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 2
3 7
4 14
5 11
6 5
7 6
8 3
9 11
10 20
11 3
12 42
13 99
14 90
15 2
16 11
17 185
18 21
19 233
20 16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026